BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 15584985)

  • 1. Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design.
    Tinmouth A; Tannock IF; Crump M; Tomlinson G; Brandwein J; Minden M; Sutton D
    Transfusion; 2004 Dec; 44(12):1711-9. PubMed ID: 15584985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients.
    Diedrich B; Remberger M; Shanwell A; Svahn BM; Ringdén O
    Transfusion; 2005 Jul; 45(7):1064-72. PubMed ID: 15987349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
    Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation.
    Webert KE; Cook RJ; Couban S; Carruthers J; Lee KA; Blajchman MA; Lipton JH; Brandwein JM; Heddle NM
    Transfusion; 2008 Jan; 48(1):81-91. PubMed ID: 17894791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
    Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
    Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 x 10(9) or 20 x 10(9) per L.
    Nevo S; Fuller AK; Zahurak ML; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 Sep; 47(9):1700-9. PubMed ID: 17725737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower or higher doses for prophylactic platelet transfusions: results of a meta-analysis of randomized controlled trials.
    Cid J; Lozano M
    Transfusion; 2007 Mar; 47(3):464-70. PubMed ID: 17319827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reticulated platelets: a reliable measure to reduce prophylactic platelet transfusions after intensive chemotherapy.
    Chaoui D; Chakroun T; Robert F; Rio B; Belhocine R; Legrand O; Salanoubat C; Lecrubier C; Casadevall N; Marie JP; Elalamy I
    Transfusion; 2005 May; 45(5):766-72. PubMed ID: 15847667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Rebulla P; Finazzi G; Marangoni F; Avvisati G; Gugliotta L; Tognoni G; Barbui T; Mandelli F; Sirchia G
    N Engl J Med; 1997 Dec; 337(26):1870-5. PubMed ID: 9407153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light.
    Murphy S; Snyder E; Cable R; Slichter SJ; Strauss RG; McCullough J; Lin JS; Corash L; Conlan MG;
    Transfusion; 2006 Jan; 46(1):24-33. PubMed ID: 16398727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet utilization and the transfusion trigger: a prospective analysis.
    Greeno E; McCullough J; Weisdorf D
    Transfusion; 2007 Feb; 47(2):201-5. PubMed ID: 17302764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation.
    Wandt H; Schaefer-Eckart K; Frank M; Birkmann J; Wilhelm M
    Bone Marrow Transplant; 2006 Feb; 37(4):387-92. PubMed ID: 16400342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.
    Bashey A; Donohue M; Liu L; Medina B; Corringham S; Ihasz A; Carrier E; Castro JE; Holman PR; Xu R; Law P; Ball ED; Lane TA
    Transfusion; 2007 Nov; 47(11):2153-60. PubMed ID: 17958545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing platelet mass versus platelet count to guide platelet transfusions in the neonatal intensive care unit.
    Gerday E; Baer VL; Lambert DK; Paul DA; Sola-Visner MC; Pysher TJ; Christensen RD
    Transfusion; 2009 Oct; 49(10):2034-9. PubMed ID: 19555422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose prophylactic platelet transfusions: time for further study, but too early for routine clinical practice.
    Strauss RG
    Transfusion; 2004 Dec; 44(12):1680-2. PubMed ID: 15584979
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
    Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG
    Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient and product factors affecting platelet transfusion results.
    Heim D; Passweg J; Gregor M; Buser A; Theocharides A; Arber C; Meyer-Monard S; Halter J; Tichelli A; Gratwohl A
    Transfusion; 2008 Apr; 48(4):681-7. PubMed ID: 18208413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of platelet transfusion triggers in a tertiary-care hospital.
    Cameron B; Rock G; Olberg B; Neurath D
    Transfusion; 2007 Feb; 47(2):206-11. PubMed ID: 17302765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
    Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
    Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed platelet engraftment in group O patients after autologous progenitor cell transplantation.
    Hoffmann S; Zhou L; Gu Y; Davenport R; Cooling L
    Transfusion; 2005 Jun; 45(6):885-95. PubMed ID: 15934986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.